GlassScriptPhysician profile
John P Davliakos
NPI 1720104995
$4,055.94
in general payments reported to CMS, 2019-2025
10 companies · $79.26 in 2025
The $79.26 reported for 2025 was less than what a typical Prosthodontics provider received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $544 · 2020: $226 · 2021: $595 · 2022: $621 · 2023: $385 · 2024: $1,606 · 2025: $79.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,124 · Food and Beverage: $946.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,123.96 |
| Food and Beverage | $946.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $1,772.85 | 2022-2025 | |
| Southern Implants North America INC | $876.22 | 2019-2024 | |
| Zimmer Biomet Holdings, INC. | $372.04 | 2019-2021 | |
| Thommen Medical USA, LLC | $353.43 | 2021-2022 | |
| Straumann USA LLC | $170.52 | 2022 | |
| Biohorizons Implant Systems INC. | $159.18 | 2019-2022 | |
| Dentsply Sirona INC | $154.44 | 2023-2024 | Orthophos E, Implant Dentistry |
| Nobel Biocare USA | $149.21 | 2019 | |
| Patterson Companies, INC. | $33.54 | 2025 | |
| Solventum Corporation | $14.51 | 2024 | 3m Relyx, Clinpro 5000 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Davliakos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.